Abdominal Neoplasms - 350 Studies Found
| Recruiting |
: The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer :
|
| Active, not recruiting |
: Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer :
|
| Terminated |
: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer :
|
| Completed |
: A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors :
|
| Active, not recruiting |
: Evaluation of Optimal Initial Treatment Duration of Bevacizumab in Combination With Standard Chemotherapy in Patients With Ovarian Cancer :
|
| Completed |
: Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer :
|
| Recruiting |
: Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer :
|
| Completed |
: Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy :
|
| Active, not recruiting |
: Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer :
|
| Active, not recruiting |
: Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer :
|